city New Delhi India hospital covid-19 Government city New Delhi India

Hetero gets DCGI nod for generic of covid drug Tocilizumab

Reading now: 238
www.livemint.com

NEW DELHI : Pharmaceutical firm Hetero on Monday said the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab for the treatment of covid-19 in hospitalized adults.

This authorization will enable medical practitioners in India to use the drug for patients who are receiving systemic corticosteroids and require supplemental oxygen, non- invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), the company said in a statement.

Hetero’s Tocira will be marketed by its associate company Hetero Healthcare in India with the support of its strong distribution network across the country.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA